168 related articles for article (PubMed ID: 33025026)
1. [PEXIVAS-The kiss of death for plasma exchange in ANCA-associated vasculitis?].
Löffler C; Hellmich B
Z Rheumatol; 2020 Nov; 79(9):910-911. PubMed ID: 33025026
[No Abstract] [Full Text] [Related]
2. PEXIVAS: The End of Plasmapheresis for ANCA-Associated Vasculitis?
De Vriese AS; Fervenza FC
Clin J Am Soc Nephrol; 2021 Feb; 16(2):307-309. PubMed ID: 32963016
[No Abstract] [Full Text] [Related]
3. Plasma exchange as an adjunctive therapy in anti-neutrophil cytoplasm antibody-associated vasculitis.
Gulati K; Pusey CD
Expert Rev Clin Immunol; 2023 Apr; 19(4):417-430. PubMed ID: 36860127
[TBL] [Abstract][Full Text] [Related]
4. Plasma Exchange in ANCA-Associated Vasculitis: For Whom (If Any)?
Walsh M
J Am Soc Nephrol; 2022 Mar; 33(3):465-466. PubMed ID: 35074935
[No Abstract] [Full Text] [Related]
5. Role of therapeutic plasmapheresis in ANCA-associated vasculitis.
Walters G
Pediatr Nephrol; 2016 Feb; 31(2):217-25. PubMed ID: 25986911
[TBL] [Abstract][Full Text] [Related]
6. PEXIVAS challenges current ANCA-associated vasculitis therapy.
Morris A; Geetha D
Nat Rev Nephrol; 2020 Jul; 16(7):373-374. PubMed ID: 32203311
[No Abstract] [Full Text] [Related]
7. Plasma exchange in ANCA-associated vasculitis: the pro position.
Kronbichler A; Shin JI; Wang CS; Szpirt WM; Segelmark M; Tesar V
Nephrol Dial Transplant; 2021 Jan; 36(2):227-231. PubMed ID: 33374018
[TBL] [Abstract][Full Text] [Related]
8. The Fate of Plasma Exchange and Glucocorticoid Dosing in ANCA-Associated Vasculitis After PEXIVAS.
Cortazar FB; Niles JL
Am J Kidney Dis; 2020 Oct; 76(4):595-597. PubMed ID: 32277949
[No Abstract] [Full Text] [Related]
9. The role of plasma exchange in antineutrophil cytoplasmic antibody-associated vasculitis: a meta-analysis.
Bellos I; Michelakis I; Nikolopoulos D
Clin Rheumatol; 2021 Apr; 40(4):1447-1456. PubMed ID: 32935248
[TBL] [Abstract][Full Text] [Related]
10. Kidney Histopathology in ANCA-Associated Vasculitides Treated with Plasma Exchange.
Casal Moura M; Soler MJ; Sethi S; Fervenza FC; Specks U
J Am Soc Nephrol; 2022 Jun; 33(6):1223-1224. PubMed ID: 35410878
[No Abstract] [Full Text] [Related]
11. Plasma exchange in antineutrophil cytoplasmic antibody-associated vasculitis--a 25-year perspective.
Szpirt WM
Nephrol Dial Transplant; 2015 Apr; 30 Suppl 1():i146-9. PubMed ID: 25770166
[TBL] [Abstract][Full Text] [Related]
12. Authors' Reply: Kidney Histopathology in ANCA-Associated Vasculitides Treated with Plasma Exchange.
Nezam D; Porcher R; Grolleau F; Terrier B;
J Am Soc Nephrol; 2022 Jun; 33(6):1224-1225. PubMed ID: 35410877
[No Abstract] [Full Text] [Related]
13. The treatment of ANCA-associated rapidly-progressive glomerulonephritis and Goodpasture syndrome with therapeutic apheresis.
Apaydin S
Transfus Apher Sci; 2018 Feb; 57(1):8-12. PubMed ID: 29503131
[TBL] [Abstract][Full Text] [Related]
14. Role of plasma exchange in ANCA-associated vasculitis.
Pimentel-Quiroz VR; Alarcón GS
Lancet Rheumatol; 2023 Oct; 5(10):e579-e580. PubMed ID: 38251481
[No Abstract] [Full Text] [Related]
15. Plasma exchange in antineutrophil cytoplasm antibody-associated vasculitis.
Walsh M
Curr Opin Nephrol Hypertens; 2014 Nov; 23(6):555-9. PubMed ID: 25144513
[TBL] [Abstract][Full Text] [Related]
16. Plasma exchange for the management of ANCA-associated vasculitis: the con position.
Specks U; Fussner LA; Cartin-Ceba R; Casal Moura M; Zand L; Fervenza FC
Nephrol Dial Transplant; 2021 Jan; 36(2):231-236. PubMed ID: 33374017
[TBL] [Abstract][Full Text] [Related]
17. Whether the addition of high-dosage methylprednisolone to plasma exchange was more effective than plasma exchange in the treatment for severe antineutrophil cytoplasmic antibody-associated vasculitis?
Cheng L; Gou SJ
Kidney Int; 2022 Mar; 101(3):647-648. PubMed ID: 35190039
[No Abstract] [Full Text] [Related]
18. Plasma Exchange and Glucocorticoids in Severe ANCA-Associated Vasculitis.
Walsh M; Merkel PA; Peh CA; Szpirt WM; Puéchal X; Fujimoto S; Hawley CM; Khalidi N; Floßmann O; Wald R; Girard LP; Levin A; Gregorini G; Harper L; Clark WF; Pagnoux C; Specks U; Smyth L; Tesar V; Ito-Ihara T; de Zoysa JR; Szczeklik W; Flores-Suárez LF; Carette S; Guillevin L; Pusey CD; Casian AL; Brezina B; Mazzetti A; McAlear CA; Broadhurst E; Reidlinger D; Mehta S; Ives N; Jayne DRW;
N Engl J Med; 2020 Feb; 382(7):622-631. PubMed ID: 32053298
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness of plasmapheresis in ANCA clearance in patients with ANCA-associated vasculitides.
Górka J; Polok K; Nowak I; Włudarczyk A; Sydor W; Padjas A; Sznajd J; Szczeklik W; Musiał J
Przegl Lek; 2016; 73(7):445-7. PubMed ID: 29676884
[TBL] [Abstract][Full Text] [Related]
20. ANCA associated vasculitis.
Hunter RW; Welsh N; Farrah TE; Gallacher PJ; Dhaun N
BMJ; 2020 Apr; 369():m1070. PubMed ID: 32291255
[No Abstract] [Full Text] [Related]
[Next] [New Search]
